Will the US Lose Its Measles Elimination Status? What the PAHO Review Actually Decides

If your child brings home a school health form this month, the question behind it — is this classroom protected against measles? — is now, unusually, also a question being decided about the entire United States.

Here is the short version. From November 10 to 13, 2026, an independent expert commission convened by the Pan American Health Organization (PAHO) is holding its sixth annual meeting in Washington, D.C., and one of its tasks is to review whether the United States still qualifies as a country that has eliminated measles — a status it has held since 2000. The U.S. Centers for Disease Control and Prevention (CDC) counted 5,182 confirmed measles cases in 2026 as of November 5, the highest annual total in more than three decades, according to the CDC and Reuters. No decision has been announced yet. The commission sends its conclusions to PAHO's director, and CDC Director Dr. Erica Schwartz told Reuters she expected a decision by early next week; KFF Health News, summarizing New York Times reporting, put the expected announcement date at November 17.



A school nurse's office is where national measles statistics become a household question. This week, an expert panel is judging the whole country's status. (Symbolic generated image)

What is actually being decided this week?

Not whether measles is a problem — on that, the case counts are not in dispute. What the commission decides is a classification, and the classification turns on one specific technical test.

PAHO's announcement of the meeting, published October 14, 2026, explains the standard in its own terms. In PAHO's wording, endemic transmission is re-established — and the elimination status is lost — when epidemiological and laboratory evidence shows that a chain of transmission involving a viral strain with an identical genotype and lineage has continued uninterrupted for 12 months or longer in a country or a defined geographical area. Imported cases do not by themselves end elimination, and neither do short outbreaks that burn out. What counts is one virus lineage, spreading inside the country, without a break, for a year or more.

That is why the review is not simply a vote on the headline case total. PAHO says the commission — the Measles and Rubella Elimination Regional Monitoring and Re-Verification Commission (RVC), an independent technical body of international experts in epidemiology, public health, virology, pediatrics and immunization — examines data for 2025 and the first half of 2026, covering vaccination coverage, the quality of epidemiological surveillance, laboratory results including molecular and virological evidence, outbreak response, and the performance of national immunization programs. PAHO states explicitly that no single source of evidence determines a country's final classification. The meeting is closed, the national reports it reviews are restricted-access, and at the end the commission submits its conclusions and recommendations to the PAHO director, who communicates the classification.

The same meeting is also reviewing Mexico and every other country in the Americas. The context matters: at its November 2025 meeting, the same commission concluded that endemic transmission had been re-established in Canada, which is currently the only country in the region classified as endemic, according to PAHO. At that 2025 meeting, the United States was classified as "sustained with major concerns," according to CIDRAP News. A separate review of the U.S. and Mexican status was originally planned for April 2026 and was moved to this regular November meeting.

How large is the 2026 resurgence, in the CDC's own numbers?

The primary source here is the CDC's measles cases and outbreaks page, updated November 6, 2026, with data as of noon on November 5:

  • Confirmed cases in 2026: 5,182 — of which 5,164 were reported by 47 jurisdictions and 18 were among international visitors to the United States.
  • Outbreaks: 43 new outbreaks reported in 2026, and 96 percent of confirmed cases (4,993 of 5,182) are outbreak-associated — 3,608 from outbreaks that began in 2026 and 1,385 from outbreaks that began in 2025. That second figure is the quiet key to this week's review: well over a thousand of this year's cases belong to transmission chains that started last year.
  • The recent trend: 285 confirmed cases in all of 2024, then 2,289 in all of 2025, then 5,182 in the first ten months of 2026. Reuters described the 2026 total as the highest number of infections in more than three decades; several outlets, including Scientific American, put the comparison year at 1991. In 2000, the year elimination was declared, the CDC recorded just 85 cases, according to CIDRAP News.
  • Vaccination coverage: kindergarten MMR (measles, mumps and rubella) coverage fell from 95.2 percent in the 2019–20 school year to 92.4 percent in 2025–26, according to the CDC — below the level of more than 95 percent community coverage the CDC cites for community immunity — leaving approximately 280,000 kindergartners at risk in the current school year. The CDC also notes that coverage varies considerably at local level, so pockets of unvaccinated people can exist inside states with high average coverage. Scientific American reported that 18 states have kindergarten MMR rates below 90 percent.
  • Vaccine effectiveness, for reference: two doses of MMR vaccine are 97 percent effective at preventing measles and one dose is 93 percent effective, according to the CDC.

One number in this story genuinely differs between sources, and it is worth being precise about it. The CDC's table records 4 deaths in 2026, with a footnote that the number is subject to change as reviews are completed, and the agency says it is working with the Council of State and Territorial Epidemiologists to develop a standardized case definition for deaths due to measles. Local and state health departments, meanwhile, have reported eight deaths connected to this year's outbreaks, according to Scientific American and CIDRAP News. Reuters, reporting the CDC director's interview, counted 11 deaths reported by state health departments since early 2025 — consistent with three in 2025 plus the eight reported for 2026. The gap is therefore about classification and review timing, not about two rival epidemics: states report first, and the CDC's national tally follows after standardized review. This explainer uses the CDC figure when it says "CDC-recorded" and the state figure when it says "state-reported," and readers should expect the two to converge over time.

Key points

  • Review: PAHO's Regional Monitoring and Re-Verification Commission meets November 10–13, 2026, in Washington, D.C., and will classify countries' measles elimination status — PAHO announcement, October 14, 2026
  • The test: endemic transmission is re-established if the same viral genotype and lineage has circulated uninterrupted for 12 months or more; no single piece of evidence decides the classification — PAHO
  • Status at stake: the United States has held measles elimination status since 2000; Canada lost its status at the commission's November 2025 meeting and is currently the region's only endemic country — PAHO
  • Cases: 5,182 confirmed in 2026 as of November 5, across 47 jurisdictions, with 43 new outbreaks and 96% of cases outbreak-associated — CDC, updated November 6, 2026
  • Trend: 285 cases in 2024 and 2,289 in 2025, per CDC — the 2026 total is the highest in more than three decades, per Reuters
  • Coverage: kindergarten MMR coverage is 92.4% in 2025–26, down from 95.2% in 2019–20 and below the CDC's >95% community-immunity benchmark — CDC
  • Deaths: 4 recorded by the CDC for 2026 (subject to change, standardized definition in development) versus 8 reported by state and local health departments — CDC; Scientific American; CIDRAP News
  • Decision timing: no ruling has been announced; the CDC director told Reuters she expected a PAHO decision by early next week, and KFF summarized the expected announcement date as November 17

Why do so many experts expect the status to be lost — and what does the CDC say?

The expert expectation rests on the calendar as much as on the case count. The current wave is generally traced to an outbreak that began in West Texas in January 2025. If the genomic evidence presented this week shows that the same lineage has circulated since then without interruption, the 12-month threshold was crossed in January 2026 — ten months ago. Several epidemiologists and infectious disease physicians told CIDRAP News that PAHO will almost certainly deem measles endemic in the United States. Jennifer Nuzzo of Brown University's Pandemic Center described the loss in CIDRAP's reporting as symbolic but real — "a loss of standing, a loss of stature, a loss of achievement" — while noting that outbreaks are now sustaining themselves and seeding new ones across the country. University of Illinois molecular epidemiologist Nídia Trovão, interviewed by her university's news bureau, likewise said the evidence strongly points to the United States losing its status, because an outbreak chain that began in January 2025 has exceeded the 12-month threshold. Scientific American reported a similar expert consensus, while noting the formal decision still rests with the commission's review of the genomic and surveillance evidence — sequencing that, as CIDRAP pointed out, cannot by itself definitively prove that every outbreak is linked, which is the one technical route by which the status could still be retained.

The federal response, as described by the official responsible for it, would not change with the label. CDC Director Dr. Erica Schwartz told Reuters on November 10 that the agency will not fundamentally change its response to measles outbreaks even if the United States loses its elimination status this month. "Let's say we did lose our measles elimination status. We're going to be doing the same exact thing that we've been doing today, which is working with the states," she said, adding that the CDC would keep emphasizing that "the number one way to prevent measles is the MMR vaccine." Schwartz pointed to closely knit communities with lower vaccination rates as the primary source of U.S. infection, and said the focus should be on reaching those communities. Reuters also reported the wider political context: Health Secretary Robert F. Kennedy Jr., who oversees the CDC, has for years cast doubt on the safety and efficacy of the MMR vaccine, and medical experts have said his rhetoric and actions have fueled falling vaccination rates; Schwartz pushed back on reports of pressure from Kennedy or his deputies, telling Reuters the decisions rest on her shoulders as director. The Department of Health and Human Services did not immediately respond to a request for comment from Scientific American. This explainer reports those positions as their holders state them; the commission's classification, when it comes, will be a technical finding about transmission, not a verdict on any official.

There is also a funding thread running underneath the science, and it connects this story to a vote covered on this site last week. Measles response — vaccination clinics, outbreak investigation, laboratory sequencing — is paid for by the same strained public-health budgets that made health-care funding the central fight in California's billionaire-tax campaign (see: Did California's billionaire tax pass? No — what Proposition 40's defeat means). Whatever PAHO decides, the work of interrupting transmission is done by state and local health departments, and their capacity is a budget question as much as a medical one.

What would losing the status actually change for a family?

Less on paper than in practice, and it is worth separating the two.

On paper: losing elimination status carries no fine, no sanction and no automatic policy change, according to the experts cited by CIDRAP News, and the CDC director has said the federal response continues unchanged. Your child's school requirements do not change because of a PAHO classification; those are set by states.

In practice, the classification is a summary of something that has already changed on the ground. A country where measles circulates continuously is a country where an unvaccinated infant, a pregnant woman, or an immunocompromised patient can encounter the virus without anyone travelling anywhere. The CDC notes that measles spreads through the air, that a person can be exposed simply by being in a room where an infected person has been, and that it is often spread at times of high travel — holidays included — and in close-quarters settings such as camps. For Canadian readers, this is not an abstract neighbouring-country story: Canada went through the same reclassification a year ago, and cross-border families face the same exposure logic on both sides.

Regaining the status is possible, and there is a recent precedent: Brazil lost its measles elimination status in 2019 and got it back in 2024, according to CIDRAP News. The route back, under the PAHO framework, runs through the same test in reverse — interrupt endemic transmission, then document at least 12 consecutive months without it, supported by strong surveillance — alongside the coverage levels PAHO describes: high and homogeneous vaccination coverage of 95 percent or higher, sensitive surveillance, strong laboratory capacity and rapid outbreak response. That is a multi-year project measured in school-entry cohorts, not in news cycles.


With kindergarten MMR coverage at 92.4% nationally — and far lower in some communities — classrooms are where the national average meets local reality. (Symbolic generated image)

What to watch

  • ☐ Early next week / November 17, 2026 — The announcement: Does PAHO's director confirm the commission's classification for the United States (and Mexico), and is the U.S. finding based on the genomic lineage evidence, the surveillance record, or both?
  • ☐ The commission's final report: PAHO says a published report will summarize the deliberations and recommendations — watch for the specific gaps it names in U.S. coverage, surveillance or outbreak response.
  • ☐ CDC weekly updates: The CDC's case page is updated weekly on Thursdays. Watch whether the 2026 total keeps climbing toward the higher year-end projections some experts have raised, and whether the CDC-recorded and state-reported death counts converge under the new standardized definition.
  • ☐ State-level coverage: The national 92.4% kindergarten figure hides the pockets that drive outbreaks. Watch state and county releases for communities still far below 95%.
  • ☐ The 12-month clock in reverse: If transmission is interrupted, the earliest a re-verification case could be built is a full year later. Watch whether outbreak chains that began in 2025 are formally declared over, state by state.
  • ☐ Other vaccine-preventable diseases: Experts cited by CIDRAP and Scientific American describe measles as the first disease to resurge when coverage falls, because it is the most contagious — watch pertussis and mumps data for the same pattern.

This explainer is reporting and analysis of a public-health classification review, not medical advice. Measles vaccination decisions are personal and medical; the CDC's position is that MMR vaccination is the best protection against measles, and your own clinician or local health department is the right source for advice about your family. Case figures are the CDC's confirmed counts as of November 5, 2026, and are preliminary and subject to change.

When a number like 92.4 percent decides whether a disease can spread in your child's school, what would help your family most — clearer local coverage data for your own school district, easier access to vaccination clinics, or something else entirely?

If you follow this blog using the Follow widget in the sidebar, explainers like this one — the day's biggest U.S. story, checked against the primary sources — will reach you as soon as they are published.

French version: Version française de cet article

Sources:






댓글

이 블로그의 인기 게시물

Enceinte au Canada ? Que faire en premier — Guide de préparation à la grossesse, partie 1 (suivi prénatal en Colombie-Britannique)

Prestations de maternité et parentales de l'assurance-emploi au Canada : comment faire sa demande, combien vous recevrez — partie 3 (montants 2026)